Roche bispecific drug Lunsumio lands European nod in follicular lymphoma

Follicular lymphoma patients in Europe now have a new treatment option. The European Commission approved Roche drug Lunsomio, a bispecific antibody designed to go after two targets to treat advanced cases of this type of cancer.